{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T21:43:32Z","timestamp":1788990212753,"version":"build-2803163510"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,2,3]],"date-time":"2020-02-03T00:00:00Z","timestamp":1580688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,2,3]],"date-time":"2020-02-03T00:00:00Z","timestamp":1580688000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007132","name":"Otsuka Pharmaceutical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007132","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Nasolacrimal duct obstruction (NLDO) is thought to be due to inflammation and fibrosis of lacrimal\u00a0duct epithelial cells (LDECs). Here we investigated the effect of rebamipide, a drug that is used for the protection of the mucosa and the treatment of gastritis and gastroduodenal ulcers, on LDECs, both <jats:italic>in vitro<\/jats:italic> and <jats:italic>in vivo<\/jats:italic>. In this study, LDECs were cultured from rabbit lacrimal duct tissues, and the barrier function of LEDCs was examined <jats:italic>in vitro<\/jats:italic> via transepithelial electrical resistance (TER) measurement, with or without interleukin (IL)-6 and\/or rebamipide. For the <jats:italic>in vivo<\/jats:italic> examination, benzalkonium chloride (BAC) was injected into the rabbit lacrimal ducts, followed by the application of rebamipide or a placebo vehicle alone. The results of the <jats:italic>in vitro<\/jats:italic> examination revealed a significant decrease in TER in the group treated with IL-6 alone compared with the placebo-vehicle group (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05) and the group treated with IL-6 and rebamipide (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01). The results of the <jats:italic>in vivo<\/jats:italic> examination revealed that the infiltration of neutrophils under the basement membrane and the disruption of tight junction proteins with BAC injection and rebamipide attenuates the disturbance of tissue construction. These results suggest that rebamipide protects LDECs via an anti-inflammatory effect and preserves the barrier function of those cells.<\/jats:p>","DOI":"10.1038\/s41598-020-58314-x","type":"journal-article","created":{"date-parts":[[2020,2,3]],"date-time":"2020-02-03T11:04:13Z","timestamp":1580727853000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Rebamipide promotes lacrimal duct epithelial cell survival via protecting barrier function"],"prefix":"10.1038","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9756-0236","authenticated-orcid":false,"given":"Hiroshi","family":"Tanaka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomomichi","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiko","family":"Tsukamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihide","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihiko","family":"Yokoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chie","family":"Sotozono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeru","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,3]]},"reference":[{"key":"58314_CR1","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/S0161-6420(86)33620-0","volume":"93","author":"JV Linberg","year":"1986","unstructured":"Linberg, J. V. & McCormick, S. A. Primary acquired nasolacrimal duct obstruction: A clinicopathologic report and biopsy technique. Ophthalmology 93, 1055\u20131063 (1986).","journal-title":"Ophthalmology"},{"key":"58314_CR2","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/eye.2014.33","volume":"28","author":"JK Lee","year":"2014","unstructured":"Lee, J. K. & Kim, T. H. Changes in cytokines in tears after endoscopic endonasal dacryocystorhinostomy for primary acquired nasolacrimal duct obstruction. Eye (Lond). 28, 600\u2013607 (2014).","journal-title":"Eye (Lond)."},{"key":"58314_CR3","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1167\/iovs.16-20717","volume":"58","author":"N Matsumura","year":"2017","unstructured":"Matsumura, N. et al. Cytokine profiles of tear fluid from patients with pediatric lacrimal duct obstruction. Invest. Ophthalmol. Vis. Sci. 58, 252\u2013256 (2017).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"58314_CR4","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1136\/bjophthalmol-2012-302868","volume":"97","author":"H Tanaka","year":"2013","unstructured":"Tanaka, H. et al. Rebamipide increases barrier function and attenuates TNF\u03b1-induced barrier disruption and cytokine expression in human corneal epithelial cells. Br. J. Ophthalmol. 97, 912\u2013916 (2013).","journal-title":"Br. J. Ophthalmol."},{"key":"58314_CR5","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s00417-015-3190-0","volume":"254","author":"M Mimura","year":"2015","unstructured":"Mimura, M. et al. Effect of rebamipide ophthalmic suspension on the success of lacrimal stent intubation. Graefe\u2019s Arch. Clin. Exp. Ophthalmol. 254, 385\u2013389 (2015).","journal-title":"Graefe\u2019s Arch. Clin. Exp. Ophthalmol."},{"key":"58314_CR6","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1631\/jzus.B1500113","volume":"16","author":"C Xie","year":"2015","unstructured":"Xie, C., Li, X. & Cui, H. Potential candidate cells for constructing tissue-engineered lacrimal duct epithelium: a histological and cytological study in rabbits. J. Zhejiang Univ. Sci. B. 16, 904\u2013913 (2015).","journal-title":"J. Zhejiang Univ. Sci. B."},{"key":"58314_CR7","doi-asserted-by":"publisher","first-page":"G621","DOI":"10.1152\/ajpheart.01063.2002","volume":"285","author":"R Yang","year":"2003","unstructured":"Yang, R. et al. IL-6 is essential for development of gut barrier dysfunction after hemorrhagic shock and resuscitation in mice. Am. J. Physiol. Liver Physiol. 285, G621\u2013G629 (2003).","journal-title":"Am. J. Physiol. Liver Physiol."},{"key":"58314_CR8","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.bbamem.2008.08.027","volume":"1788","author":"CT Capaldo","year":"2009","unstructured":"Capaldo, C. T. & Nusrat, A. Cytokine regulation of tight junctions. Biochim. Biophys. Acta. 1788, 864\u2013871 (2009).","journal-title":"Biochim. Biophys. Acta."},{"key":"58314_CR9","first-page":"623186","volume":"2011","author":"SJ Rehorek","year":"2011","unstructured":"Rehorek, S. J. et al. Development of the lacrimal apparatus in the rabbit (Oryctolagus cuniculus) and its potential role as an animal model for humans. Anat. Res. Int. 2011, 623186 (2011).","journal-title":"Anat. Res. Int."},{"key":"58314_CR10","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/0002-9394(88)90062-1","volume":"105","author":"MA Lemp","year":"1988","unstructured":"Lemp, M. A. & Zimmerman, L. E. Toxic endothelial degeneration in ocular surface disease treated with topical medications containing benzalkonium chloride. Am. J. Ophthalmol. 105, 670\u2013673 (1988).","journal-title":"Am. J. Ophthalmol."},{"key":"58314_CR11","doi-asserted-by":"publisher","first-page":"e26103","DOI":"10.1371\/journal.pone.0026103","volume":"6","author":"W Chen","year":"2011","unstructured":"Chen, W. et al. Corneal alternations induced by topical application of benzalkonium chloride in rabbit. PLoS One. 6, e26103 (2011).","journal-title":"PLoS One."},{"key":"58314_CR12","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/S0161-6420(89)32888-0","volume":"96","author":"MB Sherwood","year":"1989","unstructured":"Sherwood, M. B. et al. Long-term morphologic effects of antiglaucoma drugs on the conjunctiva and Tenon\u2019s capsule in glaucomatous patients. Ophthalmology. 96, 327\u2013335 (1989).","journal-title":"Ophthalmology."},{"key":"58314_CR13","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1097\/IOP.0b013e3181706829","volume":"24","author":"MB Kashkouli","year":"2008","unstructured":"Kashkouli, M. B. et al. Topical antiglaucoma medications and lacrimal drainage system obstruction. Ophthalmic Plast. Reconstr. Surg. 24, 172\u2013175 (2008).","journal-title":"Ophthalmic Plast. Reconstr. Surg."},{"key":"58314_CR14","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s00417-013-2484-3","volume":"252","author":"AY Nemet","year":"2014","unstructured":"Nemet, A. Y. & Vinker, S. Associated morbidity of nasolacrimal duct obstruction - A large community based case-control study. Graefe\u2019s Arch. Clin. Exp. Ophthalmol. 252, 125\u2013130 (2014).","journal-title":"Graefe\u2019s Arch. Clin. Exp. Ophthalmol."},{"key":"58314_CR15","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1007\/s10620-008-0507-4","volume":"54","author":"K Iijima","year":"2009","unstructured":"Iijima, K. et al. Rebamipide, a cytoprotective drug, increases gastric mucus secretion in human: Evaluations with endoscopic gastrin test. Dig. Dis. Sci. 54, 1500\u20131507 (2009).","journal-title":"Dig. Dis. Sci."},{"key":"58314_CR16","first-page":"1462","volume":"42","author":"K Ishihara","year":"1992","unstructured":"Ishihara, K. et al. Effect of rebamipide on mucus secretion by endogenous prostaglandin-independent mechanism in rat gastric mucosa. Arzneimittelforschung. 42, 1462\u20131466 (1992).","journal-title":"Arzneimittelforschung."},{"key":"58314_CR17","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1023\/A:1018861818023","volume":"42","author":"K Murakami","year":"1997","unstructured":"Murakami, K. et al. Rebamipide attenuates indomethacin-induced gastric mucosal lesion formation by inhibiting activation of leukocytes in rats. Dig. Dis. Sci. 42, 319\u2013325 (1997).","journal-title":"Dig. Dis. Sci."},{"key":"58314_CR18","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1007\/BF02088229","volume":"41","author":"N Yoshida","year":"1996","unstructured":"Yoshida, N. et al. Rebamipide protects against activation of neutrophils by Helicobacter pylori. Dig. Dis. Sci. 41, 1139\u20131144 (1996).","journal-title":"Dig. Dis. Sci."},{"key":"58314_CR19","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1136\/bjophthalmol-2014-305425","volume":"98","author":"K Fukuda","year":"2014","unstructured":"Fukuda, K. et al. Inhibition by rebamipide of cytokine-induced or lipopolysaccharide-induced chemokine synthesis in human corneal fibroblasts. Br. J. Ophthalmol. 98, 1751\u20131755 (2014).","journal-title":"Br. J. Ophthalmol."},{"key":"58314_CR20","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1089\/jop.2012.0054","volume":"29","author":"M Ueta","year":"2013","unstructured":"Ueta, M. et al. Rebamipide suppresses polyi:c-stimulated cytokine production in human conjunctival epithelial cells. J. Ocul. Pharmacol. Ther. 29, 688\u2013693 (2013).","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"58314_CR21","first-page":"1309","volume":"30","author":"Y Takeji","year":"2013","unstructured":"Takeji, Y. et al. Effect of rebamipide ophthalmic suspension on capsaicin-induced corneal epithelial damage in rats. Atarashii Ganka. 30, 1309\u20131313 (2013).","journal-title":"Atarashii Ganka."},{"key":"58314_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s004290050160","volume":"198","author":"F Paulsen","year":"1998","unstructured":"Paulsen, F. et al. Functional anatomy of human lacrimal duct epithelium. Anat. Embryol. (Berl). 198, 1\u201312 (1998).","journal-title":"Anat. Embryol. (Berl)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-58314-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-58314-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-58314-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T06:50:02Z","timestamp":1670309402000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-58314-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,3]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["58314"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-58314-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,3]]},"assertion":[{"value":"25 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"H.T., T.N., A.W., T.N. and S.K. received research support from Otsuka Pharmaceutical Co., Ltd. A.W. and S.K. received speakers\u2019 honoraria from Otsuka Pharmaceutical Co., Ltd. S.K served as a consultant to Otsuka Pharmaceutical Co., Ltd.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1641"}}